Evidence map›Paper›PMID 27134179›Full record

ArticleCell reports2016

Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant.

Ines G Harper, Jason M Ali, Simon J F Harper, Elizabeth Wlodek, Jawaher Alsughayyir, Margaret C Negus, M Saeed Qureshi, Reza Motalleb-Zadeh, Kourosh Saeb-Parsy, Eleanor M Bolton and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. γδ T Cells' Role in Donor-Specific Antibody Generation: Insights From Transplant Recipients and Experimental Models.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  4. Review
  5. Allorecognition Unveiled: Integrating Recent Breakthroughs Into the Current Paradigm.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Review
  6. Impact of Organ Donor Pretreatment With Anti-Thymocyte Globulin in a Murine Model of Allogenic Kidney Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Prolongation of allograft survival by passenger donor regulatory T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2019
    Article
  18. Article
  19. The Human Cell Atlas: Technical approaches and challenges.Briefings in functional genomics · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ines G HarperSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Jason M AliSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Simon J F HarperSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Elizabeth WlodekSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Jawaher AlsughayyirSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Margaret C NegusSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
M Saeed QureshiSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Reza Motalleb-ZadehSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Kourosh Saeb-ParsySchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Eleanor M BoltonSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
J Andrew BradleySchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Menna R ClatworthySchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Thomas M ConlonSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Gavin J PettigrewSchool of Clinical Medicine, University of Cambridge, Cambridge CB2 0QQ, UK. Electronic address: gjp25@cam.ac.uk.
University of Cambridge · GB

Funding

British Heart Foundation FS/10/018/28193British Heart Foundation FS/12/87/29899British Heart Foundation PG/10/002/28143Wellcome Trust
6 · The paper itself

Abstract

Chronic rejection of solid organ allografts remains the major cause of transplant failure. Donor-derived tissue-resident lymphocytes are transferred to the recipient during transplantation, but their impact on alloimmunity is unknown. Using mouse cardiac transplant models, we show that graft-versus-host recognition by passenger donor CD4 T cells markedly augments recipient cellular and humoral alloimmunity, resulting in more severe allograft vasculopathy and early graft failure. This augmentation is enhanced when donors were pre-sensitized to the recipient, is dependent upon avoidance of host NK cell recognition, and is partly due to provision of cognate help for allo-specific B cells from donor CD4 T cells recognizing B cell MHC class II in a peptide-degenerate manner. Passenger donor lymphocytes may therefore influence recipient alloimmune responses and represent a therapeutic target in solid organ transplantation.

Indexed as

Adaptive ImmunityTissue DonorsAllograftsAnimalsAutoantibodiesB-LymphocytesCD4-Positive T-LymphocytesCell DifferentiationGraft RejectionGraft vs Host DiseaseHistocompatibility Antigens Class IHistocompatibility Antigens Class IIImmunity, HumoralKiller Cells, NaturalMice, Inbred BALB CModels, ImmunologicalAutoantibodiesHistocompatibility Antigens Class IHistocompatibility Antigens Class IIPeptidesReceptors, Antigen, B-Cell

Identifiers

PMID27134179
PMCPMC4870521
OpenAlexW2343404244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.